Study Objective: The study aims to determine if tranexamic acid (TXA) is as effective as a tourniquet in improving visual clarity during arthroscopic ACL reconstruction surgery. Study Design: This is a randomized prospective controlled trial involving patients with complete ACL tears. Participants will be randomly assigned to either receive TXA or undergo surgery with a tourniquet. Data Collection: The study will use questionnaires and scales to assess the effects of TXA on visual clarity. Data will be stored securely and analyzed using the SPSS system. Ethical Considerations: Ethical guidelines will be strictly followed, including informed consent, confidentiality, and the right to withdraw from the study at any time without affecting the standard of care. Expected Outcome: The study aims to provide insights into the efficacy of TXA in improving surgical visibility, potentially influencing future protocols in arthroscopic surgeries. Results will be disseminated through academic presentations and publications.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Grading TXA
Timeframe: The questionnaire will be administered to the surgeon right after surgery is completed.
Grading Tourniquet
Timeframe: The questionnaire will be administered to the surgeon right after surgery is completed.
Grading Tourniquet vs TXA
Timeframe: The questionnaire will be administered to the surgeon right after surgery is completed.